Related Experiment Video
Updated: Feb 9, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field
Natasha Dave1, Jiao Wu1, Sandhya Thomas2,3
1Section of Nephrology, Department of Medicine, Baylor College of Medicine, Selzman Institute for Kidney Health, Houston, TX, 77030, USA.
Purpose Of Review:
Insulin resistance is an early complication of chronic kidney disease (CKD) associated with worsening cardiovascular outcomes. This review will evaluate mechanisms responsible for CKD-induced insulin resistance and therapies currently available.
Recent Findings:
Recent mechanisms have been identified including SIRPα and specific E3 ubiquitin ligases causing insulin resistance in CKD. The hallmark finding in these mechanisms is degradation of the insulin receptor substrate 1 (IRS1) which impairs intracellular insulin signaling and ultimately metabolism. The mechanisms responsible for insulin resistance in CKD include inflammation, oxidative stress, elevations in aldosterone, angiotensin II, uremic toxins, and metabolic acidosis. Potential treatments currently available for CKD-induced insulin resistance include lifestyle modification and metformin. Potential future treatments may include glucagon-like peptide agonists, SGLT2 inhibitors, and thiazolidinediones. Investigations into molecular mechanisms responsible for insulin resistance in CKD may provide new therapeutic targets while current therapies may prevent the catabolic sequelae of CKD and ameliorate its cardiovascular consequences.
Insights
Chronic kidney disease (CKD) causes insulin resistance through mechanisms like inflammation and uremic toxins, impacting metabolism. Treatments include lifestyle changes, metformin, and emerging therapies to improve outcomes.
Area of Science:
- Nephrology
- Endocrinology
- Metabolic Diseases
Background:
- Insulin resistance is an early complication of chronic kidney disease (CKD).
- CKD-associated insulin resistance contributes to adverse cardiovascular outcomes.
- Understanding these mechanisms is crucial for managing CKD patients.
Purpose of the Study:
- To review the mechanisms underlying insulin resistance in CKD.
- To evaluate currently available and potential future therapies for CKD-induced insulin resistance.
Main Methods:
- Review of recent scientific literature on CKD-induced insulin resistance.
- Analysis of identified molecular mechanisms and therapeutic strategies.
Main Results:
- Key mechanisms include SIRPα, E3 ubiquitin ligases, and degradation of insulin receptor substrate 1 (IRS1).
- Contributing factors include inflammation, oxidative stress, aldosterone, angiotensin II, uremic toxins, and metabolic acidosis.
- Current treatments involve lifestyle modification and metformin; future options include GLP-1 agonists, SGLT2 inhibitors, and thiazolidinediones.
Conclusions:
- Investigating molecular mechanisms can reveal new therapeutic targets for CKD-induced insulin resistance.
- Current therapies may mitigate catabolic complications and cardiovascular risks associated with CKD.
- Targeting insulin resistance in CKD is vital for improving patient prognosis.
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
07:22Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
Published on: September 1, 2023
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Magnetic Field Of A Current Loop
Force On A Current Loop In A Magnetic Field